Hepatitis C Elimination in Egypt: Story of Success

被引:1
|
作者
Gomaa, Asmaa [1 ]
Gomaa, Mohamed [2 ]
Allam, Naglaa [1 ]
Waked, Imam [1 ]
机构
[1] Menoufia Univ, Natl Liver Inst, Hepatol & Gastroenterol Dept, Shibin Al Kawm 32511, Egypt
[2] Univ Sherbrooke, Fac Med & Hlth Sci, Sherbrooke, PQ J1H 5N4, Canada
来源
PATHOGENS | 2024年 / 13卷 / 08期
关键词
HCV; Egypt; DAA; NCCVH; GENOTYPE; 4; PATIENTS; SUSTAINED VIROLOGICAL RESPONSE; SOFOSBUVIR PLUS RIBAVIRIN; VIRUS-INFECTION; TREATMENT PROGRAM; THERAPY; COMBINATION; SIMEPREVIR; MANAGEMENT; IMPACT;
D O I
10.3390/pathogens13080681
中图分类号
Q93 [微生物学];
学科分类号
071005 ; 100705 ;
摘要
Egypt has long been overwhelmed by the hepatitis C virus (HCV) infection, and it used to be the country with the world's highest prevalence rates. The disease had been a significant public health problem, affecting millions of Egyptians and posing severe economic and social challenges. By the early 2000s, it was estimated that around 10% of the Egyptian population was infected with HCV. However, in recent years, with the availability of direct-acting antiviral therapies, the country has made enormous steps in combating this public health threat. The combination of innovative health strategies and political will enabled Egypt to establish a successful model of care for HCV management and to be the first country to eliminate hepatitis C, setting a model for the rest of the world. In 2023, Egypt became the first country to fulfill the World Health Organization's set programmatic criteria of reduction of hepatitis C incidence and mortalities to levels close to elimination of disease or achieve the "gold tier" status on the path to disease elimination.
引用
收藏
页数:11
相关论文
共 50 条
  • [1] Hepatitis C Elimination: Opportunities and Challenges in 2023
    Taha, Gadeer
    Ezra, Levy
    Abu-Freha, Naim
    VIRUSES-BASEL, 2023, 15 (07):
  • [2] An educate, test and treat model towards elimination of hepatitis C infection in Egypt: Feasibility and effectiveness in 73 villages
    Shiha, Gamal
    Soliman, Reham
    Mikhail, Nabiel N. H.
    Easterbrook, Philippa
    JOURNAL OF HEPATOLOGY, 2020, 72 (04) : 658 - 669
  • [3] Evidence for the elimination of viral hepatitis B and C in Egypt: Results of a nationwide survey in 2022
    Kandeel, Amr
    Fahim, Manal
    Abukamar, Shimaa
    Bahaaeldin, Hala
    Abuelsood, Hanaa
    Samy, Sahar
    Deghedy, Ola
    Sheta, Amany
    Naguib, Amel
    El Guindy, Nancy
    Youssef, Amr
    Kamel, Reham
    Afifi, Salma
    El-Kassas, Moahmed
    Abdelghaffar, Khaled
    LIVER INTERNATIONAL, 2024, 44 (04) : 955 - 965
  • [4] Micro-elimination of hepatitis C in patients with chronic kidney disease: an Egyptian single-center study
    Michael, Tari George
    Anwar, Christina A.
    Ahmed, Ossama A.
    Sarhan, Iman
    Elshazly, Yehia
    Shaker, Mohammed K.
    Eltabbakh, Mohammed
    Hashem, Walaa
    Tawfic, Safaa R.
    Kamel, Shimaa Y.
    Kandil, Doaa M.
    Naguib, Gina G.
    Khedr, Abdelrahman
    Ghanem, Eman A.
    Dabbous, Hany
    Doss, Wahid
    El-Sayed, Manal H.
    EGYPTIAN JOURNAL OF INTERNAL MEDICINE, 2022, 34 (01)
  • [5] Elimination of hepatitis C in Egypt: unprecedented achievement despite challenges
    Saied, AbdulRahman A.
    Kamal, Zeinab
    Roomi, Ali B.
    Metwally, Asmaa A.
    JOURNAL OF TRAVEL MEDICINE, 2024, 31 (02)
  • [6] Advancing Hepatitis C Elimination in Africa: Insights from Egypt
    Salomon, Izere
    Olivier, Sibomana
    Egide, Ndayambaje
    HEPATIC MEDICINE-EVIDENCE AND RESEARCH, 2024, 16 : 37 - 44
  • [7] The case for a universal hepatitis C vaccine to achieve hepatitis C elimination
    Scott, Nick
    Wilson, David P.
    Thompson, Alexander J.
    Barnes, Eleanor
    El-Sayed, Manal
    Benzaken, Adele Schwartz
    Drummer, Heidi E.
    Hellard, Margaret E.
    BMC MEDICINE, 2019, 17 (01)
  • [8] Pursuing Elimination of Hepatitis C in Egypt: Cost-Effectiveness and Economic Evaluation of a Country-Wide Program
    Schwander, Bjoern
    Feldstein, Josh
    Sulo, Suela
    Gonzalez, Luis
    ElShishiney, Galal
    Hassany, Mohamed
    INFECTIOUS DISEASES AND THERAPY, 2022, 11 (03) : 1193 - 1203
  • [9] Hepatitis C models of care: approaches to elimination
    Biondi, Mia J.
    Feld, Jordan J.
    CANADIAN LIVER JOURNAL, 2020, 3 (02): : 165 - 176
  • [10] Insulin resistance and hepatitis C: an evolving story
    Eslam, Mohammed
    Khattab, Mahmoud AboElneen
    Harrison, Stephen A.
    GUT, 2011, 60 (08) : 1139 - 1151